Close Menu

NEW YORK (GenomeWeb) – Researchers with the PATHSEEK consortium have developed a method to quickly sequence Mycobacterium tuberculosis from sputum samples, rather than having to wait the weeks it can take to culture bacterial samples.

By using biotinylated RNA baits to grab full M. tuberculosis sequences from their samples, the researchers reported in the Journal of Clinical Microbiology today that they could generate sequences and analyze them for drug-resistance genes within a clinically relevant timeframe of up to 96 hours.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

US President Donald Trump has threatened to cut World Health Organization funding over its pandemic response, which would affect its ability to do its work and which he might not be able to do.

Following discrimination allegations, NICHD's Constantine Stratakis withdraws from a new position at the Research Institute of the McGill University Health Center, Science reports.

The US Securities and Exchange Commission has halted the sales of a handful of stocks over claims made about the coronavirus.

In Nature this week: comparative analyses of single-cell RNA sequencing protocols uncover differences between approaches, and more.

Sponsored by

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.

Sponsored by
10x Genomics

Uveal melanoma (UM) is a highly metastatic cancer that, in contrast to cutaneous melanoma, is largely unresponsive to checkpoint immunotherapy.